Markenbildchenweg 6
D-56068 Koblenz
fon + 49 (0) 261 14833
fax + 49 (0) 261 15293

Mo bis Fr 08.00 - 12.00 Uhr
Di 14.00 - 17.00 Uhr
Do 15.00 - 18.00 Uhr
und täglich 11.00 - 12.00 Uhr
offene Sprechstunde (nach
telefonischer Anmeldung)

DKG Deutsche Krebsgesellschaft  Zertifiziertes Prostatakrebs Zentrum

      Dr. med. K. Taymoorian   Dr. med.
K. Taymoorian


1.Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
Hoffmann MA, Taymoorian K, Ruf C, Gerhards A, Leyendecker K, Stein T, Jakobs FM, Schreckenberger M.
Anticancer Res. 2017 Dec;37(12):6871-6877.

2.Diagnostic significance of multiparametric MRI combined with US-fusion guided biopsy of the prostate in patients with increased PSA levels and negative standard biopsy results to detect significant prostate cancer - Correlation with the Gleason score. Korrelation mit dem Gleason Score].
Hoffmann M, Hoffmann MA, Wieler HJ, Jakobs FM, Taymoorian K, Gerhards A, Miederer M, Schreckenberger M.
Nuklearmedizin. 2017 Aug 14;56(4):147-155. doi: 10.3413/Nukmed-0871-16-12. Epub 2017 Jul 17. German.
PMID: 28715042

3. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.

Taymoorian K, Thomas A, Slowinski T, Khiabanchian M, Stephan C, Lein M, Deger S, Lenk S, Loening SA, Fischer T.
Anticancer Res. 2007 Nov-Dec;27(6C):4315-20.

4. Thermal therapy of prostate cancer using magnetic nanoparticles

Johannsen M, Gneveckow U, Taymoorian K, Cho CH, Thiesen B, Scholz R, Waldöfner N, Loening SA, Wust P, Jordan A.
Actas Urol Esp. 2007 Jun;31(6):660-7. Review. Spanish.

5. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial.
Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldöfner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA.
Int J Hyperthermia. 2007 May;23(3):315-23.

6. Flank hernia and bulging after open nephrectomy: mesh repair by flank or median approach? Report of a novel technique.
Zieren J, Menenakos C, Taymoorian K, Müller JM.
Int Urol Nephrol. 2007;39(4):989-93. Epub 2007 Mar 1

7. Arrival time parametric imaging: a new ultrasound technique for quantifying perfusion of kidney grafts.

Fischer T, Filimonow S, Rudolph J, Morgera S, Budde K, Slowinski T, Ebeling V, Taymoorian K, Giessing M, Thomas A.
Ultraschall Med. 2008 Aug;29(4):418-23. Epub 2007 Feb 21.

8. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P.
Eur Urol. 2007 Dec;52(6):1653-61. Epub 2006 Nov 17.

9. Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entities.
Maza S, Taupitz M, Taymoorian K, Winzer KJ, Rückert J, Paschen C, Räber G, Schneider S, Trefzer U, Munz DL.
Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):378-83. Epub 2006 Oct 11.

10. Body size and weight as predisposing factors in varicocele.
May M, Taymoorian K, Beutner S, Helke C, Braun KP, Lein M, Roigas J, Hoschke B.
Scand J Urol Nephrol. 2006;40(1):45-8.

11. MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging.
Beyersdorff D, Taymoorian K, Knösel T, Schnorr D, Felix R, Hamm B, Bruhn H.
AJR Am J Roentgenol. 2005 Nov;185(5):1214-20

12. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldöfner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A.
Prostate. 2006 Jan 1;66(1):97-104.

13. Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.

Abramjuk C, Jung K, Krell HW, Juchem R, Peters R, Taymoorian K, Staack A, Stephan C, Schnorr J, Loening SA, Lein M.
Anticancer Drugs. 2005 Sep;16(8):855-61.

14. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldöfner N, Scholz R, Koch M, Lein M, Jung K, Loening SA.
Prostate. 2005 Aug 1;64(3):283-92

15. Thermoradiotherapy using interstitial self-regulating thermoseeds: an intermediate analysis of a phase II trial.

Deger S, Taymoorian K, Boehmer D, Schink T, Roigas J, Wille AH, Budach V, Wernecke KD, Loening SA.
Eur Urol. 2004 May;45(5):574-9; discussion 580.

16. The effect of dopexamine and iloprost on plasma disappearance rate of indocyanine green in patients in septic shock.
Birnbaum J, Lehmann C, Taymoorian K, Krausch D, Wauer H, Gründling M, Spies C, Kox WJ.
Anaesthesist. 2003 Nov;52(11):1014-9. German.

17. A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrations.
Lein M, Kwiatkowski M, Semjonow A, Luboldt HJ, Hammerer P, Stephan C, Klevecka V,
Taymoorian K, Schnorr D, Recker F, Loening SA, Jung K.
J Urol. 2003 Oct;170(4 Pt 1):1175-9.

18. Effects of 13-cis-retinoic acid on chemoimmunotherapy of metastatic renal cell carcinoma--results of a retrospective analysis.
Roigas J, Deger S, Taymoorian K, Wille AH, Johannsen M, Türk I, Schnorr D, Loening SA.
Cancer Biother Radiopharm. 2003 Apr;18(2):157-63.

19. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock.
Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ.
Intensive Care Med. 2000 Oct;26(10):1557-60